Table 3. Lipinski and Veber rules of selected diazole-thiole compounds (1-6).
Compound | MW | iLogP | HBD (nOHNH) | HBA (nON) | nrotb | MR | TPSA | Lipinski #violations | Bio availability score |
Lipinski* | ≤500 | ≤5 | ≤5 | ≤10 | ≤10 | - | - | ||
Veber** | - | - | - | - | - | - | ≤ 140 | ||
1 | 441.91 | 3.09 | 2 | 5 | 6 | 114.93 | 150.24 | 0 | 0.55 |
2 | 451.52 | 3.03 | 2 | 6 | 8 | 121.22 | 159.47 | 0 | 0.55 |
3 | 421.5 | 3.1 | 2 | 5 | 6 | 114.89 | 150.24 | 0 | 0.55 |
4 | 407.47 | 2.71 | 2 | 5 | 6 | 109.92 | 150.24 | 0 | 0.55 |
5 | 452.47 | 2 | 2 | 7 | 7 | 118.74 | 196.06 | 0 | 0.55 |
6 | 486.36 | 3.16 | 2 | 5 | 6 | 117.62 | 150.24 | 0 | 0.55 |
Azithromycin | 748.98 | 4.76 | 5 | 14 | 7 | 200.78 | 180.08 | 2 | 0.17 |
Sulfanilamide | 172.2 | 0.61 | 2 | 3 | 1 | 41.84 | 94.56 | 0 | 0.55 |
Sulfamethoxazole | 253.28 | 1.03 | 2 | 4 | 3 | 62.99 | 106.6 | 0 | 0.55 |